| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/20/2006 | WO2006041121A1 Remedies/preventives for chronic skin disease |
| 04/20/2006 | WO2006041019A1 Process for producing 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl]-1,3-propanediol hydrochloride or hydrate thereof and intermediate for the same |
| 04/20/2006 | WO2006041015A1 Amino alcohol derivative, addition salt thereof and immunosuppressive agent |
| 04/20/2006 | WO2006040980A1 Lecithinized superoxide dismutase composition and process for producing the same |
| 04/20/2006 | WO2006040485A2 Macromolecule obtained from a bifidobacterium culture and use thereof for the prevention and treatment of inflammatory rheumatisms |
| 04/20/2006 | WO2006040451A2 Novel 9h-pyrido[2,3-b]indole derivatives serving as cdk and gsk3 inhibitors, method for the preparation thereof, and the pharmaceutical compositions containing such compounds |
| 04/20/2006 | WO2006039792A1 Method of treating autoimmune diseases |
| 04/20/2006 | WO2006021803A3 Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases |
| 04/20/2006 | WO2006021335A3 Peptide mixture from peptides having a molecular weight of from 1000 to 5000 dalton |
| 04/20/2006 | WO2006018609A3 Anti-inflammatory agents |
| 04/20/2006 | WO2006009755A3 Azaindoles modulating c-kit activity and uses therefor |
| 04/20/2006 | WO2006004749A3 Compositions and methods for treating neurological disorders |
| 04/20/2006 | WO2005097183A3 Treatment of diseases |
| 04/20/2006 | US20060084809 Compounds as PDE IV and TNF-inhibitors |
| 04/20/2006 | US20060084789 Immunotherapeutic and immunoprphylactic reagents |
| 04/20/2006 | US20060084699 Antagonists of the B2 receptor of bradykinin; analgesics; hyperalgesia and major algesia; cancer; nontoxic; industrial scale; 5-[[(2,4-dichloro-3-methylphenyl)sulphonyl]methylamino]-N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-N-methyl-pentanamide |
| 04/20/2006 | US20060084685 Ophthalmological use of roflumilast for the treatment of diseases of the eye |
| 04/20/2006 | US20060084684 Topically applicable pharmaceutical preparation |
| 04/20/2006 | US20060084667 New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 04/20/2006 | US20060084661 IL-8 receptor antagonists |
| 04/20/2006 | US20060084653 Beta-sheet mimetics and composition and methods relating thereto |
| 04/20/2006 | US20060084646 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 04/20/2006 | US20060084641 IL-8 receptor antagonists |
| 04/20/2006 | US20060084613 Dipeptide enzyme inhibitor; antiinflammatory agents; autoimmune disease; wound healing agents |
| 04/20/2006 | US20060084598 Administering to the patient about 15 to about 360 mg of alpha-1-antitrypsin per kg patient body mass, and repeating the administration at least once with a periodicity of between 3 and 31 days |
| 04/20/2006 | US20060084588 Modulation of immune function |
| 04/20/2006 | US20060084143 Screen for agonists and antagonists; treat solid tumors, vascular deficiencies; polypeptide, polynucleotide, plasmid; chemotherapeutic agents, alkylating agents, antimetabolites, vinca alkaloids, plant extracts, nitrosoureas, topoisomerase inhibitors, platinum analogs, adrenocortical suppressants |
| 04/20/2006 | US20060084121 OX2 receptor homologs |
| 04/20/2006 | US20060083784 Amorphous pharmaceutical compositions |
| 04/20/2006 | US20060083754 Pharmaceutical combinations comprising corticoids and immunosuppressants for treating corticoid- and/or calcineurin inhibitors-resistant diseases |
| 04/20/2006 | US20060083740 By modulating the expression of mutant and wild type CD83 gene products produced in a mammal; regulation of T cell and dendritic cell activity; antibodies |
| 04/20/2006 | CA2584169A1 Remedies/preventives for chronic skin disease |
| 04/20/2006 | CA2583846A1 Process for producing 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl]-1,3-propanediol hydrochloride or hydrates thereof, and intermediates in the production thereof |
| 04/20/2006 | CA2583269A1 Macromolecule obtained from a bifidobacterium culture and use thereof for the prevention and treatment of inflammatory rheumatisms |
| 04/20/2006 | CA2580271A1 Method for treating vasculitis |
| 04/19/2006 | EP1647599A2 Quantitative method for detecting yessotoxins in fish products based on the activation caused by the toxin in cellular phosphodiesterase and therapeutic usefulness of said activation |
| 04/19/2006 | EP1647597A1 Chemokine N-terminal deletion mutations |
| 04/19/2006 | EP1647545A1 Antiviral protease inhibitors |
| 04/19/2006 | EP1647256A1 Dendritic cell infiltrativity activating composition and immune activator |
| 04/19/2006 | EP1646657A1 Antibodies to cd44 vra and methods of use |
| 04/19/2006 | EP1646656A2 Human antibody molecules for il-13 |
| 04/19/2006 | EP1646427A1 Cpg-packaged liposomes |
| 04/19/2006 | EP1646400A1 Treatment of allergic diseases using a modulator of the notch signaling pathway |
| 04/19/2006 | EP1646395A2 Methods and compositions for regulating lymphocyte activity |
| 04/19/2006 | EP1448184B1 Use of propionyl l-carnitine or one of its pharmacologically acceptable salts for the preparation of a medicine for the treatment of la peyronie s disease |
| 04/19/2006 | EP1387838B1 Cyanoanthranilamide derivatives and the use thereof as medicaments |
| 04/19/2006 | EP1317428B1 Pyrrolidine-2-carboxylic acid hydrazide derivatives for use as metalloprotease inhibitors |
| 04/19/2006 | EP1296959B1 Methods and compositions utilizing quinazolinones |
| 04/19/2006 | EP1296692B1 Use of a formulation made of or containing at least one dissimilated milk serum |
| 04/19/2006 | EP1294724B1 Pyrrolo¬2,3-d|pyrimidine compounds as immunosuppressive agents |
| 04/19/2006 | EP1259125B1 Inulin products with improved nutritional properties |
| 04/19/2006 | EP1210112B1 Vaccine against hbv and hpv |
| 04/19/2006 | EP1051177B1 Steroid 3-o-sulphamate derivatives as inhibitors of oestrone sulphatase |
| 04/19/2006 | EP1044197B1 Piperidinyl-substituted pyridylalkane, alkene and alkyne carboxamides as cytostatic agents and immunosuppressants |
| 04/19/2006 | EP1003479B1 Method and compositions for treating late phase allergic reactions and inflammatory diseases |
| 04/19/2006 | EP0789574B1 Use of naked polynucleotides in the manufacture of a medicament for treating tumours |
| 04/19/2006 | CN1761672A Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 04/19/2006 | CN1761664A Immunomodulating heterocyclic compounds |
| 04/19/2006 | CN1761652A Cathepsin S inhibitors |
| 04/19/2006 | CN1760360A Microorganism strain GM-090 of lactobacillus fermentum and its use for stimulating INF-y secretion and/or treating allergy |
| 04/19/2006 | CN1759852A Prescription of epimedium drop pills, an dpreparation method |
| 04/19/2006 | CN1759739A Sauce of soft-shell turtle |
| 04/19/2006 | CN1252241C Health wine for strengthening immunity and its preparing method |
| 04/19/2006 | CN1252079C Novel substance having physiological activity, process for producing the same, and use |
| 04/19/2006 | CN1252071C Xanthine Phosphodiesterase V inhibitors |
| 04/19/2006 | CN1252070C Urea substituted imidazoquinolines |
| 04/19/2006 | CN1252068C Heteroaryl derivatives as superior ligands for nociceptin receptor ORL-1 |
| 04/19/2006 | CN1252067C Benzazole derivatives and their use as JNK modulators |
| 04/19/2006 | CN1252065C Cinnoline compounds |
| 04/19/2006 | CN1252040C Novel aryl, alkenyl and alkynl 4-dedimethylamino tetracycline derivatives |
| 04/19/2006 | CN1251761C Vaccine comprising cytokine-induced heat shock proteins |
| 04/19/2006 | CN1251713C Chinese traditional medicine preparation for preventing and treating bee diseases |
| 04/19/2006 | CN1251697C Composition with functions of regulating immunity and resisting fatigue and its prepn, use and quality control method |
| 04/19/2006 | CN1251678C Medicinal composition and tuchahoe extract for raising immunity |
| 04/19/2006 | CN1251676C Phenyl xanthine derivative |
| 04/19/2006 | CN1251613C Health care food for anti-oxidation and immunoregulation and its making method |
| 04/18/2006 | USRE39072 2-aminopropane-1,3-diol compounds, medicinal use thereof, and intermediates in synthesizing the same |
| 04/18/2006 | US7030246 Tetrahydroquinoline derivatives as stat6-modulators, preparation and use thereof |
| 04/18/2006 | US7030242 Selective inhibition of aggrecanase in osteoarthritis treatment |
| 04/18/2006 | US7030225 Antibodies to JTT-1 protein, cells secreting such antibodies, and methods of making such antibodies |
| 04/18/2006 | US7030219 Nucleotide sequences coding protein for use in treatment of cancer and prevention of viral infection |
| 04/18/2006 | US7030218 Extending ligation technique to peptides, polypeptides, other polymers and other molecules via an amide bond; used in the synthesis of optionally polymer-modified, synthetic bioactive proteins, and of pharmaceutical compositions |
| 04/18/2006 | US7030211 Antigenic peptides derived from telomerase |
| 04/18/2006 | US7030131 such as N-[4-(4-amino-1H-imidazol[4,5-c]quinolin-1-yl)butyl]-5-(dimethylamino)-naphthalenesulfonamide; for induction of biosynthesis of cytokines; immunomodulators; antineoplastic agents |
| 04/18/2006 | US7030129 Method of reducing and treating UVB-induced immunosuppression |
| 04/18/2006 | US7030123 Indole derivatives with vascular damaging activity |
| 04/18/2006 | US7030090 Immune-modulating peptide |
| 04/18/2006 | US7030086 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 04/18/2006 | US7029914 DNA encoding SNORF36 receptors |
| 04/18/2006 | US7029898 Comprises chimeric polypeptide with hydrolase and mitogen activated protein kinase activity for diagnosis and treatment of cell proliferation and differentiation disorders |
| 04/18/2006 | US7029877 binding protease thrombin to phosphoethanolamine binding protein |
| 04/18/2006 | US7029872 Methods for producing modified glycoproteins |
| 04/18/2006 | US7029684 Antigenic composition of a Pseudomonas aeruginosa |
| 04/18/2006 | US7029678 Vaccines |
| 04/18/2006 | US7029674 contacting an immune cell with an agent that modulates the interaction between PD-1 and a PD-1 ligand (e.g., soluble forms of PD-1 or PD-1 ligand or antibodies to PD-1); inhibits signaling via PD-1 |
| 04/18/2006 | US7029658 Delivery of antidepressants through an inhalation route |
| 04/18/2006 | CA2268825C Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
| 04/13/2006 | WO2006039418A2 Human monoclonal antibodies to fc gamma receptor ii (cd32) |
| 04/13/2006 | WO2006038738A1 Receptor function regulating agent |
| 04/13/2006 | WO2006038656A1 Allergy suppressant |